Leukapheresis Market Size

Leukapheresis Market size was over USD 208.76 million in 2024 and is anticipated to cross USD 755.52 million by 2037, growing at more than 10.4% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of lubricants is estimated at USD 226.13 million. The demand for leukapheresis is driven by an increasing incidence of leukemia, as leukapheresis is a critical medical procedure to trealeukemia. As per a report, in 2023, there will be 1,958,310 new cancer cases diagnosed in the US; of these, leukemia, lymphoma, and myeloma cases are predicted to make up 9.4%. Leukapheresis is a procedure to remove white blood cells that may be used for other medical purposes, such as stem cell transplantation and immunotherapy. The need for leukapheresis to support these treatments is increasing as the incidence of leukemia increases, and this has led to an increase in sales.

Leukapheresis can be performed to harvest stem cells from children for other cancer patients as well as to treat or eliminate excess WBCs in children with lymphoma. Leukapheresis is a market focus because of its potential and advantages in this application, particularly as children's leukapheresis treatment is now only available in a small number of hospitals in developed and developing nations. Therefore, this factor is propelling the growth of the leukapheresis market.